gamma-secretase modulators (Sumitomo Dainippon)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Namegamma-secretase modulators (Sumitomo Dainippon)
Drug Alias Namegamma-secretase modulators (Dainippon Sumitomo Pharma)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBeta amyloid A4 protein inhibitorsGamma-secretase modulators
TargetsBeta amyloid A4 proteinGamma-secretase
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSumitomo Pharmaceuticals Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSumitomo Pharmaceuticals Co Ltd
Active IndicationsN/A
Inactive IndicationsAlzheimer Disease

Other Information

ATC CodeN/A
Related LinksN/A